Complement-Based Drug Development Summit leaderboard
  • Thursday, August 27, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 310

Author

Pharma Journalist 9023 posts 0 comments

Tetra Bio-Pharma Enters into a Strategic Partnership with Avicanna

Feb 15, 2022
Tetra Bio-Pharma Inc. a leader in cannabinoid-derived drug discovery and development announced that it has executed a non-binding term sheet with Avicanna Inc. ("Avicanna") to assess…
Read More...

Singapore Health Sciences Authority Issues Interim Authorization for Novavax COVID-19 Vaccine

Feb 15, 2022
Novavax, Inc. announced that the Singapore Health Sciences Authority (HSA) has issued interim authorization for Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted) for active…
Read More...

Collegium to Acquire BioDelivery Sciences Broadening Pain Portfolio

Feb 15, 2022
Collegium Pharmaceutical, Inc. and BioDelivery Sciences International, Inc. announced a definitive agreement pursuant to which Collegium will acquire BDSI for $5.60 per share in cash.…
Read More...

Axcella Therapeutics Announces FDA Fast Track Designation for AXA1125 in NASH

Feb 15, 2022
Axcella Therapeutics, a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions,…
Read More...

Pfizer and BioNTech Provide Update on Rolling Submission for Emergency Use Authorization of Their…

Feb 14, 2022
 Pfizer Inc. and BioNTech SE announced plans to extend their rolling submission to the U.S. Food and Drug Administration (FDA) seeking to amend the Emergency Use Authorization of the…
Read More...

RNA therapeutics is at a critical stage following the success of the COVID-19 mRNA vaccines

Feb 14, 2022
RNA therapeutics is at a critical stage following the success of the COVID-19 mRNA vaccines. Beyond mRNA vaccines, innovative developments are being made using siRNA, microRNA, tRNA and…
Read More...

Quoin Pharmaceuticals Signs Exclusive Distribution Agreement with ER-Kim for its Lead Asset, QRX003,…

Feb 14, 2022
Quoin Pharmaceuticals Ltd. announced that its wholly-owned subsidiary, Quoin Pharmaceuticals, Inc., has entered into an exclusive Distribution Agreement with ER-Kim, a partner for…
Read More...

Bayer Receives FDA Fast Track Designation for asundexian Stroke Program

Feb 14, 2022
Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its investigational drug asundexian (BAY2433334) as a potential treatment…
Read More...

Novartis India Limited extends access to its medicines in India by signing exclusive sales and…

Feb 14, 2022
Novartis India Limited (NIL) announced an exclusive sales and distribution agreement with Dr. Reddy’s Laboratories (Dr. Reddy’s) for a few of its Established Medicines which includes…
Read More...

Asymchem Acquires Snapdragon Chemistry

Feb 14, 2022
Asymchem Laboratories (Tianjin) Co., Ltd. announced its agreement to acquire Snapdragon Chemistry, Inc., a US-based chemical technology company providing industry-leading expertise in…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • REGENXBIO Delays RGX-121 Filing After Spine MRI Findings
  • Lundbeck Wins EU Orphan Designation for Cushing’s Syndrome Drug
  • Takeda Wins Japan Approval for New Narcolepsy Type 1 Drug
  • GSK Wins Japan Approval for Hepatitis B Functional Cure
  • Gossamer Bio Secures Up to $250 Million for Seralutinib

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.